Rafferty Asset Management, LLC Mirum Pharmaceuticals, Inc. Transaction History
Rafferty Asset Management, LLC
- $22.9 Billion
- Q1 2025
A detailed history of Rafferty Asset Management, LLC transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 51,857 shares of MIRM stock, worth $2.77 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
51,857
Previous 45,160
14.83%
Holding current value
$2.77 Million
Previous $1.87 Million
25.12%
% of portfolio
0.01%
Previous 0.01%
Shares
11 transactions
Others Institutions Holding MIRM
# of Institutions
231Shares Held
55.9MCall Options Held
27.4KPut Options Held
105K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.8MShares$363 Million19.27% of portfolio
-
Janus Henderson Group PLC London, X04.77MShares$254 Million0.12% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$173 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.8MShares$149 Million5.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.54MShares$136 Million0.0% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.96B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...